Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2006 | 11-2005 | 08-2005 | 05-2005 | 02-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,437 | 41,889 | 28,350 | 20,493 | 9,443 |
| Depreciation Amortization | 3,183 | 9,912 | 6,512 | 3,892 | 1,986 |
| Income taxes - deferred | 790 | 4,403 | 5,172 | 4,104 | 2,464 |
| Accounts receivable | -5,356 | -29,272 | -11,376 | -15,291 | -29,353 |
| Accounts payable and accrued liabilities | 24,961 | 25,668 | 14,113 | 21,715 | 22,259 |
| Other Working Capital | -4,989 | -22,158 | -20,256 | -14,101 | -16,492 |
| Other Operating Activity | -18,236 | 8,176 | -1,972 | -5,899 | 7,428 |
| Operating Cash Flow | $6,790 | $38,618 | $20,543 | $14,913 | $-2,265 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,390 | -17,070 | -9,666 | -4,524 | -2,168 |
| Net Acquisitions | -2,013 | -34,845 | -6,473 | -5,131 | -253 |
| Other Investing Activity | 0 | 0 | -2,500 | 0 | 0 |
| Investing Cash Flow | $-7,403 | $-51,915 | $-18,639 | $-9,655 | $-2,421 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -3,000 | N/A | -1,000 |
| Debt Repayment | -1,000 | -11,133 | -2,000 | -4,000 | -2,000 |
| Common Stock Issued | 1,799 | 2,175 | 2,041 | 1,842 | 631 |
| Financing Cash Flow | $799 | $-8,958 | $-2,959 | $-2,158 | $-2,369 |
| Beginning Cash Position | 41,240 | 63,495 | 63,495 | 63,495 | 63,495 |
| End Cash Position | 41,426 | 41,240 | 62,440 | 66,595 | 56,440 |
| Net Cash Flow | $186 | $-22,255 | $-1,055 | $3,100 | $-7,055 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,790 | 38,618 | 20,543 | 14,913 | -2,265 |
| Capital Expenditure | -5,390 | -17,070 | -9,666 | -4,524 | -2,168 |
| Free Cash Flow | 1,400 | 21,548 | 10,877 | 10,389 | -4,433 |